ASXL1 and acute myeloid leukemia: The ASXL1 G646fs*12 mutation accounts for approximately half of all ASXL1 mutations in AML [13] and approximately 39% of all ASXL1 mutations in reported BPDCN cases (Supplemental Table S1).